Naproxen Pharmacogenetic Study (Project 1, Aim 2)
Condition(s):PharmacogeneticsLast Updated:June 29, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):PharmacogeneticsLast Updated:June 29, 2020Recruiting
Condition(s):Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome p450 CYP2C19 VariantLast Updated:November 3, 2020Completed
Condition(s):Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination Therapy vs. Oseltamivir Alone for Hospitalised Paediatric Influenza PatientsLast Updated:March 19, 2020Completed
Condition(s):Pain; Other Surgical Procedures; Impacted Third Molar ToothLast Updated:November 4, 2016Completed
Condition(s):Gastric UlcerLast Updated:June 6, 2018Completed
Condition(s):Heterotopic OssificationLast Updated:December 20, 2021Active, not recruiting
Condition(s):T Cells; Colorectal Cancer; Lynch SyndromeLast Updated:June 9, 2022Not yet recruiting
Condition(s):HealthyLast Updated:January 23, 2020Completed
Condition(s):Osteoarthritis, KneeLast Updated:March 22, 2012Unknown status
Condition(s):Alzheimer Disease; Cognitive Decline Due to Alzheimer Disease; Mild Cognitive Impairment Due to Alzheimer DiseaseLast Updated:August 1, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.